Randomized, double-blind, double-dummy, 12-week, active-controlled study of pitavastatin 4 mg daily(QD) vs. pravastatin 40 mg daily(QD) in subjects with primary hyperlipidemia or mixed dyslipidemia.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
328
pitavastatin 4 mg once daily (QD)
Pravastatin 40 mg once daily (QD)
Mean Percent Change in Low Density Lipoprotein Cholesterol(LDL-C) From Baseline to Week 12
Time frame: Baseline and 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Huntsville, Alabama, United States
Unnamed facility
Muscle Shoals, Alabama, United States
Unnamed facility
Chandler, Arizona, United States
Unnamed facility
Goodyear, Arizona, United States
Unnamed facility
Phoenix, Arizona, United States
Unnamed facility
Beverly Hills, California, United States
Unnamed facility
Los Angeles, California, United States
Unnamed facility
Newport Beach, California, United States
Unnamed facility
Colorado Springs, Colorado, United States
Unnamed facility
Clearwater, Florida, United States
...and 34 more locations